Systemic therapy for unresectable, mixed hepatocellular-cholangiocarcinoma: treatment of a rare malignancy

BACKGROUND: Combined hepatocellular-cholangiocarcinoma (HCC-CC) has a reported incidence of less than 5% of primary hepatic malignancies. The treatment approach to this malignancy is undefined. Our objective of this case series is to provide some insight into chemotherapy and/or targeted therapy in...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Gastrointest Oncol
Главные авторы: Rogers, Jane E., Bolonesi, Ryan M., Rashid, Asif, Elsayes, Khaled M., Elbanan, Mohamed G., Law, Lindsey, Kaseb, Ahmed, Shroff, Rachna T.
Формат: Artigo
Язык:Inglês
Опубликовано: AME Publishing Company 2017
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5401851/
https://ncbi.nlm.nih.gov/pubmed/28480073
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2017.03.03
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы